Adhesive Interactions in Hemostasis

Acta Haematologica

Volumn 97, Issue 1-2, 1997, Pages 118-125

  Rosenfeld, Stephen J ^a   Gralnick, Harvey R ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Collagen; Fibrinogen; GPIb IX; GPIIb IIIa; Integrins; Von Willebrand factor

Indexed keywords

CELL ADHESION MOLECULE; COLLAGEN; FIBRIN; VON WILLEBRAND FACTOR;

BLOOD COMPONENT; BLOOD FLOW; BLOOD VESSEL WALL; CELL ADHESION; CELL SURFACE; HEMOSTASIS; HUMAN; PRIORITY JOURNAL; REVIEW; THROMBOCYTE ACTIVATION; THROMBOCYTE SHAPE;

ANIMALS; BINDING SITES; BIOPOLYMERS; BLOOD PLATELET DISORDERS; CELL ADHESION; COLLAGEN; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; FIBRIN; FIBRINOGEN; HEMOSTASIS; HUMANS; PLATELET ADHESIVENESS; PLATELET MEMBRANE GLYCOPROTEINS; VON WILLEBRAND FACTOR;

EID: 15144341607     PISSN: 00015792     EISSN: 14219662     Source Type: Journal    
DOI: 10.1159/000203667     Document Type: Article

References (106)

1. Rosenfcld SJ, Gralnick HR: von Willebrand’s Disease; in Ratnoff OD, Forbes CD, (eds): Disorders of Hemostasis. Philadelphia, Saunders, 1996, p 186.
2. JafYc EA, Hoyer LW, Nachman RL: Synthesis of von Willcbrand factor by cultured human endothelial cells. Proc Natl Acad Sei USA 1974;71:1906.
3. Sporn LA, Chavin SI, Marder VJ, Wagner DD: Biosynthesis of von Willebrand protein by human megakaryocytes. J Clin Invest 1985;76: 1102.
4. Nachman R, Levine R, Jaffe EA: Synthesis of factor VIII antigen by cultured guinea pig megakaryocytes. J Clin Invest 1977;60:914.
5. Ewenstein BM, Warhol MJ, Handin RI, Pober JS: Composition of the von Willebrand factor storage organelle (Wcibel-Palade body) isolated from cultured human umbilical vein endothelial cells. J Cell Biol 1987,104:1423.
6. Adelman B, Carlson P, Powers P: von Wille-brand factor is present on the surface of platelets stimulated in plasma by ADP. Blood 1987; 70:1362.
7. Wcncel DJ, Plow EF, Zimmerman TS. Painter RG, Ginsberg MH: Immunofluorescent localization of adhesive glycoproteins in resting and thrombin-stimulated platelets. Am J Pathol 1984,115:156.
8. Wencel DJ, Painter RG, Zimmermann TS, Ginsberg MH: Ultrastructural localization of human platelet thrombospondin, fibrinogen, fibronectin, and von Willebrand factor in frozen thin section. Blood 1985;65:929.
9. Fowler WE, Frctto LI, Hamilton KK. Erickson HP, McKee PA: Substructure of human von Willebrand factor. J Clin Invest 1985:76:1491.
10. Wagner DD, Lawrence SO, Ohlsson WB, Fay PJ, Marder VJ: Topology and order of formation of interchain disulfide bonds in von Wille-brand factor. Blood 1987;69:27.
11. Zimmerman TS, Roberts J, Edgington TS: Fac-tor-VIII-related antigen: Multiple molecular forms in human plasma. Proc Natl Acad Sei USA 1975:72:5121.
12. Dent JA, Galbuscra M, Ruggcri ZM: Heterogeneity of plasma von Willcbrand factor multi-mers resulting from proteolysis of the constituent subunit. J Clin Invest 1991:88:774.
13. Bolhuis PA, Sakariassen KS, Sander HJ. Bou-ma BN, Sixma JJ: Binding of factor VUI-von Willcbrand factor to human arterial subendothelium precedes increased platelet adhesion and enhances platelet spreading. J Lab Clin Med 1981:97:568.
14. Ruan C, Tobelem G, McMichacl AJ, Drouet L, Legrand Y, Degos L, Kieffcr N, Lee H, Caen JP: Monoclonal antibody to human platelet glycoprotein I. II. Effects on human platelet function. Br J Haematol 1981:49:511.
15. Coller BS, Pccrschkc EI, Scudder LE. Sullivan CA: Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willcbrand factor to platelets: additional evidence in support of GPlb as a platelet receptor for von Willcbrand factor. Blood 1983:61:99.
16. DeMarco L, Shapiro SS: Properties of human asialo-factor VIII. A ristocetin-independent platelet-aggregating agent. J Clin Invest 1981; 68:321.
17. Williams SB, McKeown LP, Gralnick HR: Asialo von Willcbrand factor binding to and aggregation of platelets: Effects of inhibitors of platelet metabolism and function. J Lab Clin Med 1987;109:560.
18. Howard MA, Firkin BG: Ristocetin: A new tool in the investigation of platelet aggregation. Thromb Diath Haemorrh 1971;26:362.
19. White GC 2d, Workman EF Jr, Lundblad RL: Thrombin binding to thrombasthenic platelets. J Lab Clin Med 1978;91:76.
20. Hoeprich PJ, Doolittle RF: Dimeric half-mole-cules of human fibrinogen are joined through disulfide bonds in an antiparallel orientation. Biochemistry 1983;22:2049.
21. Rixon MW. Chan WY, Davie EW, Chung DW: Characterization of a complementary deoxyribonucleic acid coding for the alpha chain of human fibrinogen. Biochemistry 1983:22: 3237.
22. Chung DW. Que BG, Rixon MW, Mace MJ, Davie EW: Characterization of complementary deoxyribonucleic acid and genomic deoxyribonucleic acid for the beta chain of human fibrinogen. Biochemistry 1983:22:3244.
23. Chung DW, Chan WY. Davie EW: Characterization of a complementary' deoxyribonucleic acid coding for the gamma chain of human fibrinogen. Biochemistry 1983:22:3250.
24. Kant JA, Lord ST, Crabtree GR: Partial mRNA sequences for human A alpha, B beta, and gamma fibrinogen chains: Evolutionary and functional implications. Proc Natl Acad Sci USA 1983:80:3953.
25. Olaisen B, Teisberg P, Gcdde-Dahl TJ: Fibrinogen gamma chain locus is on chromosome 4 in man. Human Genet 1982;61:24.
26. Henry I, Uzan G, Weil D, Nicolas H,: The genes coding for A alpha-, B beta-, and gamma-chains of fibrinogen map to 4q2. Am J Hum Genet 1984;36:760.
27. Kant JA, Fomace AJ, Saxe D, Simon MI, McBride OW, Crabtree GR: Evolution and organization of the fibrinogen locus on chromosome 4: Gene duplication accompanied by transposition and inversion. Proc Natl Acad Sci USA 1985:82:2344.
28. Fowlkes DM, Mullis NT, Comeau CM. Crabtree GR: Potential basis for regulation of the coordinately expressed fibrinogen genes: homology in the 5' flanking regions. Proc Natl Acad Sci USA 1984;81:2313.
29. Marguerie GA, Plow EF, Edgington TS: Human platelets possess an inducible and saturable receptor specific for fibrinogen. J Biol Chem 1979:254:5357.
30. Mustard JF, Packham MA, Kinlough RR. Perry DW, Rcgocczi E: Fibrinogen and ADP-induced platelet aggregation. Blood 1978:52: 453.
31. Hawiger J, Timmons S, Kloczewiak M, Strong DD, Doolittle RF: gamma and alpha chains of human fibrinogen possess sites reactive with human platelet receptors. Proc Natl Acad Sci USA 1982:79:2068.
32. Kloczewiak M. Timmons: Recognition site for the platelet receptor is present on the 15-rcsidue carboxy-terminal fragment of the gamma chain of human fibrinogen and is not involved in the fibrin polymerization reaction. Thromb Res 1983:29:249.
33. Kloczewiak M, Timmons S, Lukas TJ, Hawiger J: Platelet receptor recognition site on human fibrinogen: Synthesis and structure-function relationship of peptides corresponding to the car-boxy-tcrminal segment of the gamma chain. Biochemistry 1984;23:1767.
34. Lam SC, Plow EF, Smith MA, Andrieux A, Ryckwaert JJ. Marguerie G, Ginsberg MH: Evidence that arginyl-glycyl-aspartate peptides and fibrinogen gamma chain peptides share a common binding site on platelets. J Biol Chem 1987:262:947.
35. Kloczewiak M, Timmons S. Bednarck MA, Sa-kon M, Hawiger J: Platelet receptor recognition domain on the gamma chain of human fibrinogen and its synthetic peptide analogues. Biochemistry 1989:28:2915.
36. Andrieux A, Hudry CG. Ryckewaert JJ. Chapel A. Ginsberg MH, Plow EF, Marguerie G: Amino acid sequences in fibrinogen mediating its interaction with its platelet receptor. GPlIb-Illa.J Biol Chem 1989:264:9258.
37. Farrell DH, Thiagarajan P: Binding of recombinant fibrinogen mutants to platelets. J Biol Chem 1994:269:226.
38. Farrell DH. Thiagarajan P, Chung DW, Davie EW: Role of fibrinogen alpha and gamma chain sites in platelet aggregation. Proc Natl Acad Sci USA 1992:89:10729.
39. Weisel JW. Nagaswami C. Vilaire G. Bennett JS: Examination of the platelet membrane glycoprotein Ilb-Illa complex and its interaction with fibrinogen and other ligands by electron microscopy. J Biol Chem 1992;267:16637.
40. Hawiger J, Kloczewiak M. Bednarek MA, Timmons S: Platelet receptor recognition domains on the alpha chain of human fibrinogen: structure-function analysis. Biochemistry 1989:28: 2909.
41. Coller BS: Interaction of normal, thrombasthenic, and Bernard-Soulier platelets with immobilized fibrinogen: Defective platclet-fibrin-ogen interaction in thrombasthenia. Blood 1980:55:169.
42. Savage B. Ruggeri ZM: Selective recognition of adhesive sites in surface-bound fibrinogen by glycoprotein Ilb-Illa on nonactivated platelets. J Biol Chem 1991:266:11227.
43. Beer JH. Springer KT. Coller BS: Immobilized Arg-Gly-Asp (RGD) peptides of varying lengths as structural probes of the platelet glycoprotein Ilb/IIIa receptor. Blood 1992;79:117.
44. Bennett JS, Shattil SJ, Power JW, Gartner TK: Interaction of fibrinogen w ith its platelet receptor. Differential effects of alpha and gamma chain fibrinogen peptides on the glycoprotein Ilb-IIIa complex. J Biol Chem 1988;263: 12948.
45. Olexa SA, Budzynski AZ: Evidence for four different polymerization sites involved in human fibrin formation. Proc Natl Acad Sci USA 1980;77:1374.
46. Laudano AP, Doolittle RF: Synthetic peptide derivatives that bind to fibrinogen and prevent the polymerization of fibrin monomers. Proc Natl Acad Sci USA 1978;75:3085.
47. Shainoff JR. Dardik BN: Fibrinopeptidc B and aggregation of fibrinogen. Science 1979,204: 200.
48. Laudano AP, Doolittle RF: Influence of calcium ion on the binding of fibrin amino terminal peptides to fibrinogen. Science 1981:212: 457.
49. Weisel JW: Fibrin assembly: Lateral aggregation and the role of the two pairs of fibrinopep-tides. BiophysJ 1986:50:1079.
50. Kehrel B: Platelet-collagcn interactions. Semin Thromb Hemost 1995;21:123.
51. Rauterberg J, Jaeger E, Althaus M: Collagens in atherosclerotic vessel wall lesions. Curr Top Pathol 1993:87:163.
52. Saelman EU, Nieuwcnhuis HK, Hese KM. dc Groot PG, Heijnen HF, Sage EH, Williams S, McKeown L, Gralnick HR, Sixma JJ: Platelet adhesion to collagen types I through VIII under conditions of stasis and flow is mediated by GPIa/IIa (alpha 2 beta 1-integrin). Blood 1994: 83:1244.
53. Santoro SA: Identification of a 160,000 dalton platelet membrane protein that mediates the initial divalent cation-dependent adhesion of platelets to collagen. Cell 1986;46:913.
54. Nieuwenhuis HK, Akkcrman JW, Houdjik WP, Sixma JJ: Human blood platelets showing no response to collagen fail to express surface glycoprotein la. Nature 1985:318:470.
55. Kehrel B, Balleisen L, Kokott R. Mesters R, Stenzinger W, Clemetson KJ, van de Loo J: Deficiency of intact thrombospondin and membrane glycoprotein la in platelets with defective collagen-induced aggregation and spontaneous loss of disorder. Blood 1988;71:1074.
56. Weston SA, Hulmes DJ, Mould AP, Watson RB, Humphries MJ: Identification of integrin alpha 2 beta 1 as cell surface receptor for the carboxyl-terminal propeptide of type I procollagen. J Biol Chem 1994:269:20982.
57. Moroi M, Jung SM, Okuma M, Shinmyozu K: A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion. J Clin Invest 1989:84: 1440.
58. Staatz WD, Rajpara SM, Wayner EA, Carter WG, Santoro SA: The membrane glycoprotein Ia-IIa (VLA-2) complex mediates the Mg**-dependent adhesion of platelets to collagen. J Cell Biol 1989;108:1917.
59. Tandon NN, Kralisz U, Jamieson GA: Identification of glycoprotein IV (CD36) as a primary receptor for platclet-collagen adhesion. J Biol Chem 1989:264:7576.
60. Kchrcl B, Kronenberg A,: Platelets deficient in glycoprotein Illb aggregate normally to collagens type I and III but not to collagen type V. Blood 1993:82:3364.
61. Ruggeri ZM: The platelet glycoprotein Ib-IX complex. Prog Hemost Thromb 1991; 10:35.
62. Du X, Bcutler L, Ruan C, Castaldi PA. Berndt MC: Glycoprotein lb and glycoprotein IX arc fully complexed in the intact platelet membrane. Blood 1987:69:1524.
63. Andrews RK, Fox JE: Identification of a region in the cytoplasmic domain of the platelet membrane glycoprotein Ib-IX complex that binds to purified actin-binding protein. J Biol Chem 1992:267:18605.
64. Takahashi N, Takahashi Y, Putnam FW: Periodicity of leucine and tandem repetition of a 24-amino acid segment in the primary structure of leucine-rich alpha 2-glycoprotein of human scrum. Proc Natl Acad Sci USA 1985;82: 1906.
65. Hynes RO: Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 1992:69: 11.
66. Calvete JJ: On the structure and function of platelet integrin alpha lib beta 3, the fibrinogen receptor. Proc Soc Exp Biol Med 1995;208: 346.
67. Iscnbcrg WM, McEver RP. Phillips DR, Shuman MA, Bainton DF: The platelet fibrinogen receptor: An immunogold-surface replica study of agonist-induced ligand binding and receptor clustering. J Cell Biol 1987; 104:1655.
68. Bennett JS, Vilaire G: Exposure of platelet fibrinogen receptors by ADP and epinephrine. J Clin Invest 1979,64:1393.
69. Sims PJ, Ginsberg MH, Plow EF, Shattil SJ: Effect of platelet activation on the conformation of the plasma membrane glycoprotein Ilb-Illa complex. J Biol Chem 1991;266:7345.
70. O’Toole TE, Katagiri Y, Faull RJ. Peter K. Tamura R. Quaranta V, Loftus JC, Shattil SJ, Ginsberg MH: Integrin cytoplasmic domains mediate inside-out signal transduction. J Cell Biol 1994:124:1047.
71. Hillery CA, Smyth SS. Parise: Phosphorylation of human platelet glycoprotein Ilia (GPIIIa): Dissociation from fibrinogen receptor activation and phosphorylation of GPIIIa in vitro. J Biol Chem 1991;266:14663.
72. Du XP, Plow EF, Frclingcr AL 3d. O'Toole TE, Loftus JC, Ginsberg MH: Ligands activate in-tegrin alpha lib beta 3 (platelet GPlIb-lIIa). Cell 1991;65:409.
73. Mustard JF, Kinlough RR, Packham MA. Perry DW. Harfenist EJ, Pai KR: Comparison of fibrinogen association with normal and throm-basthenic platelets on exposure to ADP or Chymotrypsin. Blood 1979;54:987.
74. Frelinger AL 3d. Lam SC, Plow EF, Smith MA, Loftus JC, Ginsberg MH: Occupancy of an adhesive glycoprotein receptor modulates expression of an antigenic site involved in cell adhesion. J Biol Chem 1988:263:12397.
75. Savage B, Marzec UM, Chao BH. Harkcr LA, Maraganorc JM, Ruggeri ZM: Binding of the snake venom-derived proteins applaggin and cchistatin to the arginine-glycine-aspartic acid recognition sitc(s) on platelet glycoprotein Ilb.IIIa complex inhibits receptor function. J Biol Chem 1990:265:11766.
76. Lazarus RA, McDowell RS: Structural and functional aspects of RGD-containing protein antagonists of glycoprotein Ilb-IIIa. Curr Opin Biotechnol 1993:4:438.
77. Smyth SS, Hillery CA, Parise LV: Fibrinogen binding to purified platelet glycoprotein Ilb-Illa (integral alpha lib beta 3) is modulated by lipids. J Biol Chem 1992,267:15568.
78. Plow EF, Srouji AH. Meyer D. Marguerie G, Ginsberg MH: Evidence that three adhesive proteins interact with a common recognition site on activated platelets. J Biol Chem 1984; 259:5388.
79. Fox JE: The platelet cytoskclcton. Thromb Haemost 1993;70:884.
80. Wayner EA, Carter WG, Piotrowicz RS, Ku-nicki TJ: The function of multiple extracellular matrix receptors in mediating cell adhesion to extracellular matrix: preparation of monoclonal antibodies to the fibronectin receptor that specifically inhibit cell adhesion to fibronectin and react with platelet glycoproteins Ic-IIa. J Cell Biol 1988:107:1881.
81. Ill CR, Engvall E, Ruoslahti E: Adhesion of platelets to laminin in the absence of activation. J Cell Biol 1984:99:2140.
82. Weiss HJ. Meyer D, Rabinowitz R. Pietu G. Girma JP, Vicic WJ, Rogers J: Pscudo-von Willebrand’s disease: An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molccular-weight multimers. N Engl J Med 1982:306:326.
83. Berndt MC, Gregory C, Chong BH, Zola H, Castaldi PA: Additional glycoprotein defects in Bemard-Soulicr’s syndrome: confirmation of genetic basis by parental analysis. Blood 1983; 62:800.
84. Ware J, Russell SR, Vicente V, Scharf RE, Tomer A, McMillan R, Ruggeri ZM: Nonsense mutation in the glycoprotein lb alpha coding sequence associated with Bernard-Soulier syndrome. Proc Natl Acad Sei USA 1990;87: 2025.
85. Miller JL, Lyle VA, Cunningham D: Mutation of lcucine-57 to phenylalanine in a platelet glycoprotein lb alpha leucine tandem repeat occurring in patients with an autosomal dominant variant of Bernard-Soulier disease. Blood 1992;79:439.
86. Wright SD, Michaclides K. Johnson DJ, West NC, Tuddcnham EG: Double heterozygosity for mutations in the platelet glycoprotein IX gene in three siblings with Bernard-Soulier syndrome. Blood 1993:81:2339.
87. Ware J. Russell SR, Marchese P, Murata M, Mazzucato M. De Marco L. Ruggeri ZM: Point mutation in a lcucinc-rich repeat of platelet glycoprotein lb alpha resulting in the Bernard-Soulier syndrome. J Clin Invest 1993;92:1213.
88. Simsek S, Admiraal LG, Modderman PW, van der Schoot CE, von dem Borne AE: Identification of a homozygous single base pair deletion in the gene coding for the human platelet glycoprotein lb alpha causing Bernard-Soulier syndrome. Thromb Haemost 1994;72:444.
89. Clemetson JM, Kyrlc PA, Brenner B, Clemet-son KJ: Variant Bernard-Soulier syndrome associated with a homozygous mutation in the leucine-rich domain of glycoprotein IX. Blood 1994:84:1124.
90. Li C, Martin SE, Roth GJ: The genetic defect in two well-studied cases of Bernard-Soulier syndrome: a point mutation in the fifth leucine-rich repeat of platelet glycoprotein lb alpha. Blood 1995:86:3805.
91. Bernard J: History of congenital hemorrhagic thrombocytopathic dystrophy. Blood Cells 1983,9:179.
92. Bcllucci S, Tobelem G, Caen JP: Inherited platelet disorders. Prog Hematol 1983; 13: 223.
93. Bithell TC, Parekh SJ, Strong RR: Platelet-function studies in the Bernard-Soulier syndrome. Ann NY Acad Sci 1972;201:145.
94. Walsh PN, Mills DC, Pareti FI, Stewart GJ, Macfarlane DE, Johnson MM, Egan JJ: Hereditary giant platelet syndrome: Absence of collagen-induced coagulant activity and deficiency of factor-XI binding to platelets. Br J Haematol 1975;29:639.
95. Olson JD, Moake JL, Collins MF, Michael BS: Adhesion of human platelets to purified solid-phase von Willebrand factor: studies of normal and Bernard-Soulier platelets. Thromb Res 1983;32:115.
96. George JN, Reimann TA, Moake JL. Morgan RK. Cimo PL, Sears DA: Bernard-Soulier disease: A study of four patients and their parents. Br J Haematol 1981:48:459.
97. Cohen I, Glaser T, Seligsohn U: Effects of ADP and ATP on bovine fibrinogen- and ristocetin-induced platelet aggregation in Glanz-mann’s thrombasthenia. BrJ Haematol 1975; 31:343.
98. Phillips DR, Agin PP: Platelet membrane defects in Glanzmann’s thrombasthenia. J Clin Invest 1977;60:535.
99. Nurden AT, Caen JP: The different glycoprotein abnormalities in thrombasthénie and Bernard-Soulier platelets. Semin Hematol 1979:16:234.
100. Reichert N, Seligsohn U, Ramot B: Clinical and genetic aspects of Glanzmann’s thrombasthenia in Israel: report of 22 cases. Thromb Diath Haemorrh 1975;34:806.
101. Zucker MB, Pert JH, Hilgartncr MW: Platelet function in a patient with thrombasthenia. Blood 1966:28:524.
102. Sakariasscn KS,: The role of platelet membrane glycoproteins lb and Ilb-IIIa in platelet adherence to human artery subendothclium. Br J Haematol 1986,63:681.
103. Weiss HJ, Turitto VT, Baumgartner HR: Platelet adhesion and thrombus formation on subendothelium in platelets deficient in glycoproteins Ilb-IIIa, lb, and storage granules. Blood 1986:67:322.
104. Weiss HJ, Hawiger J, Ruggeri ZM, Turitto VT, Thiagarajan P, Hoffmann T: Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein Ilb-IIIa complex at higher shear rate. J Clin Invest 1989:83:288.
105. Legrand C, Caen JP: Binding of 14C-ADP by thrombasthénie platelet membranes. Haemostasis 1976;5:231.
106. Caen JP, Michel H: Platelet shape change and aggregation. Nature 1972;240:148